Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Hanson

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The American Journal of Otology|May 23, 2000
Comparison of postoperative headache after retrosigmoid approach: vestibular nerve section versus vestibular schwannoma resectionC G Jackson, B M McGrew, J A Forest, et al.
In Vitro|July 1, 1983
The proliferation of human tumor cell lines in the presence of different agars, agaroses, and methyl celluloseE J Pavlik, D E Kenady, J R Van Nagell, et al.
Steroids|April 1, 1984
VisiCalc and VisiPlot software routines and the analysis of data routinely encountered in steroid biochemistryE J Pavlik, K Nelson, J R van Nagell, et al.
Cytometry|January 1, 1986
Programming for the DNA analysis of FCM data on an IBM microcomputerE J Pavlik, R C Flanigan, J Bartmas, et al.
Clinical Chemistry|April 1, 1985
Steroid receptor analysis by size-exclusion liquid chromatography: considerations for the clinical laboratoryE J Pavlik, K Nelson, J R van Nagell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivityE J Pavlik, D E Kenady, J R van Nagell, et al.
Cancer Investigation|January 1, 1985
Esterase activity, exclusion of propidium iodide, and proliferation in tumor cells exposed to anticancer agents: phenomena relevant to chemosensitivity determinationsE J Pavlik, R C Flanigan, J R van Nagell, et al.
Cancer|May 15, 1986
Phase II clinical trial using californium 252 fast neutron brachytherapy, external pelvic radiation, and extrafascial hysterectomy in the treatment of bulky, barrel-shaped stage IB cervical cancerJ R van Nagell, Y Maruyama, E S Donaldson, et al.
Biochemistry|December 31, 1985
Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligandsE J Pavlik, K Nelson, J R van Nagell, et al.
Cancer Investigation|January 1, 1984
Stability of doxorubicin in relation to chemosensitivity determinations: loss of lethality and retention of antiproliferative activityE J Pavlik, D E Kenady, J R van Nagell, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The American Journal of Otology|May 23, 2000
Comparison of postoperative headache after retrosigmoid approach: vestibular nerve section versus vestibular schwannoma resectionC G Jackson, B M McGrew, J A Forest, et al.
In Vitro|July 1, 1983
The proliferation of human tumor cell lines in the presence of different agars, agaroses, and methyl celluloseE J Pavlik, D E Kenady, J R Van Nagell, et al.
Steroids|April 1, 1984
VisiCalc and VisiPlot software routines and the analysis of data routinely encountered in steroid biochemistryE J Pavlik, K Nelson, J R van Nagell, et al.
Cytometry|January 1, 1986
Programming for the DNA analysis of FCM data on an IBM microcomputerE J Pavlik, R C Flanigan, J Bartmas, et al.
Clinical Chemistry|April 1, 1985
Steroid receptor analysis by size-exclusion liquid chromatography: considerations for the clinical laboratoryE J Pavlik, K Nelson, J R van Nagell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivityE J Pavlik, D E Kenady, J R van Nagell, et al.
Cancer Investigation|January 1, 1985
Esterase activity, exclusion of propidium iodide, and proliferation in tumor cells exposed to anticancer agents: phenomena relevant to chemosensitivity determinationsE J Pavlik, R C Flanigan, J R van Nagell, et al.
Cancer|May 15, 1986
Phase II clinical trial using californium 252 fast neutron brachytherapy, external pelvic radiation, and extrafascial hysterectomy in the treatment of bulky, barrel-shaped stage IB cervical cancerJ R van Nagell, Y Maruyama, E S Donaldson, et al.
Biochemistry|December 31, 1985
Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligandsE J Pavlik, K Nelson, J R van Nagell, et al.
Cancer Investigation|January 1, 1984
Stability of doxorubicin in relation to chemosensitivity determinations: loss of lethality and retention of antiproliferative activityE J Pavlik, D E Kenady, J R van Nagell, et al.
Pageof 4